Elutia Stock (NASDAQ: ELUT) stock price, news, charts, stock research, profile.
Open | $3.940 |
Close | $3.830 |
Volume / Avg. | 21.283K / 16.635K |
Day Range | 3.631 - 4.090 |
52 Wk Range | 1.100 - 4.390 |
Market Cap | $94.234M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 64 |
Short Interest | 0.07% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Elutia (NASDAQ:ELUT) through any online brokerage.
Other companies in Elutia’s space includes: Anixa Biosciences (NASDAQ:ANIX), CytomX Therapeutics (NASDAQ:CTMX), Connect Biopharma Hldgs (NASDAQ:CNTB), FibroGen (NASDAQ:FGEN) and Armata Pharmaceuticals (AMEX:ARMP).
There is no analysis for Elutia
Elutia has a consensus price target of $4.00.
The stock price for Elutia (NASDAQ: ELUT) is $3.87 last updated June 14, 2024 at 8:00 AM EDT.
There are no upcoming dividends for Elutia.
Elutia’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Elutia.
Elutia is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.